Irbesartan belongs to the angiotensin II receptor blocker (ARB) class of medicines, which are used to manage high blood pressure and certain kidney conditions. In Hong Kong, irbesartan is available as a prescription-only pill in two strengths-150 mg and 300 mg. The drug is regulated by the Hong Kong Department of Health under the Pharmacy and Poisons Ordinance. It is marketed without a proprietary brand name; the ingredient name itself serves as the generic label.
Irbesartan blocks the AT₁ (angiotensin II type 1) receptor on blood-vessel smooth muscle and adrenal cells. By preventing angiotensin II from binding, the medication:
The onset of action typically occurs within 2 hours, with a therapeutic effect that lasts about 24 hours, allowing once-daily dosing. Irbesartan is well absorbed from the gastrointestinal tract and undergoes hepatic metabolism, mainly via CYP2C9. Approximately 60-80 % of the dose reaches systemic circulation unchanged (bioavailability).
These indications are recognized by the Hong Kong Department of Health and align with international regulatory approvals. The medication is intended for adults; pediatric use is not established.
Off-label use requires careful medical supervision and individualized risk assessment.
Absolute contraindications
Relative contraindications / cautions
Special populations such as lactating mothers, patients with chronic kidney disease, or those on multiple antihypertensives should discuss the risk-benefit balance with their healthcare provider.
These effects are usually transient and resolve without intervention.
If any of these symptoms appear, seek immediate medical attention.
Standard dosing:
Initial: 150 mg once daily.
Titration: If needed, increase to 300 mg once daily after 2-4 weeks, based on blood-pressure response.
Renal or hepatic impairment:
Start at 150 mg; monitor renal function and potassium before dose escalation.
Administration:
Swallow the tablet whole with a glass of water.
It may be taken with or without food.
Missed dose:
Take the missed dose as soon as remembered unless it is near the time of the next scheduled dose. Do not double the dose.
Overdose:
Symptoms may include severe hypotension, dizziness, and syncope. Seek emergency care; supportive measures (e.g., intravenous fluids) are the mainstay of treatment.
Discontinuation:
Irbesartan can be stopped abruptly, but blood pressure should be monitored to avoid rebound hypertension. In certain situations, a gradual taper may be advised by the prescriber.
This article provides educational information about irbesartan and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Irbesartan can be used in patients with mild to moderate chronic kidney disease, but renal function and serum potassium should be monitored closely. In severe renal impairment, dose adjustment or alternative therapy may be required.
Some weight-loss products contain herbal ingredients (e.g., licorice) that can affect potassium levels or blood pressure. It is advisable to disclose all supplements to your pharmacist or physician before starting irbesartan.
Take the missed dose as soon as you remember if enough time remains before the next scheduled dose. Otherwise, skip the missed dose and continue with your regular dosing schedule. Maintaining a consistent once-daily interval helps sustain blood-pressure control.
Yes, manufacturers often imprint strength-specific codes on the tablet surface (e.g., “IR 150” vs. “IR 300”). Verify the imprint against the pharmacy label to ensure you have the correct dosage.
A modest dietary potassium intake is generally acceptable, but excessive potassium (e.g., from large amounts of banana, orange juice, or salt substitutes) may raise serum potassium levels. Periodic blood tests will guide whether dietary restrictions are needed.
Combination therapy with a thiazide can enhance blood-pressure control and is commonly prescribed. However, monitoring for low sodium, low blood pressure, and kidney function is recommended.
Moderate alcohol intake does not significantly alter irbesartan’s effect, but excessive drinking may cause additional blood-pressure fluctuations and increase dizziness risk.
Most patients notice a reduction in systolic and diastolic pressure within 2-4 weeks, though the full therapeutic effect may continue to develop over several weeks.
Irbesartan is sometimes used off-label for heart failure when ACE inhibitors are not tolerated, but it is not formally approved for this purpose in Hong Kong. Consultation with a cardiologist is essential before such use.
Do not flush tablets down the toilet. Return them to a pharmacy take-back program or follow the Hong Kong Department of Health’s guidelines for disposing of medicines in household waste after sealing them in a non-transparent container.
